Catalyst Wire Dossier Catalyst Wire Dossier

aliskiren/amlodipine/hydrochlorothiazide

· Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for aliskiren/amlodipine/hydrochlorothiazide, covering 2021-06-07 to 2021-06-07. Get the full timeline:

Most recent: Clinical Trial Update: A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension [Phase 3]

See pricing